+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Actelion Pharmaceuticals Ltd.  - logo

Actelion Pharmaceuticals develops drugs for pulmonary arterial hypertension treatments that cover the spectrum of diseases ranging from WHO functional class (FC) II through to FC IV, with oral, inhaled, and intravenous medications. Actelion has operative affiliates in over 30 countries. The company was founded in 1997 and is based in Allschwil, Switzerland. Actelion Pharmaceuticals Ltd. operates as a subsidiary of Actelion Ltd.

From
From
From
From
From
From
From
From
From
From
DNA-Encoded Libraries: Platforms and Services Market - Product Thumbnail Image

DNA-Encoded Libraries: Platforms and Services Market

  • Report
  • January 2019
  • 133 Pages
From
From
From
Disease Analysis: Pulmonary Hypertension - Product Thumbnail Image

Disease Analysis: Pulmonary Hypertension

  • Drug Pipelines
  • April 2021
  • 78 pages
From
Loading Indicator
adroll